As genomic medicine evolves, health systems are embedding pharmacogenomics into pharmacy operations, not only as a research function but as a clinical asset to personalize patient treatment and reduce adverse effects. Here are responses from four pharmacy leaders who were…
CMS proposed in July to expedite its payment reduction for some 340B items and services until it recoups $7.8 billion. Hospital systems are pushing back. To compensate for underpayments in the 340B program between 2018 and 2022, CMS policy codified…
Novo Nordisk reported results from its phase 3 clinical trial for its experimental obesity drug cagrilintide which showed significant weight loss among participants. The research, presented at the 2025 European Association for the Study of Diabetes congress in Vienna, found…
Elie Bahou, PharmD, former chief pharmacy officer at Renton, Wash.-based Providence, has joined pharmacy company Hercules Pharmaceuticals as executive vice president and chief pharmacy strategy officer. Dr. Bahou previously led integrated pharmacy operations at Providence, focusing on payer-provider collaboration, supply…
The U.S. Court of Appeals for the 5th Circuit upheld a Mississippi court decision to deny drugmaker AbbVie’s request for a preliminary injunction against a state law protecting access to 340B drug pricing. The ruling follows a coalition of hospital…
The federal government is awarding a contract to Rensselaer Polytechnic Institute to investigate the association between vaccines and autism. The Troy, N.Y.-based engineering school is receiving the no-bid contract due to what HHS said is the school’s “unique ability” to…
The FDA is moving to scale back its long-standing use of expert panels to review drug applications, KFF Health News reported Sept. 12. George Tidmarsh, MD, PhD, director of the FDA’s Center for Drug Evaluation and Research, said the agency…
A group of House lawmakers is urging HHS to scrap or revise its proposed 340B rebate model pilot program, warning the model could dismantle the original intent of the program and harm safety-net providers. Here are five things to know:
In early 2024, the American Society of Health-System Pharmacists (ASHP) reported a record 323 active drug shortages, many affecting sterile injectable medications. This situation was exacerbated later in the year by a disruption in IV fluid production due to Hurricane Helene,…
A child enrolled in Capsida Biotherapeutics’ gene therapy trial for STXBP1 developmental and epileptic encephalopathy has died, prompting the company to pause the study while investigating the death. The patient was the first participant in the clinical trial. Capsida said…
